Selected article for: "ELISA specific and immunosorbent assay"
Author: Chow, Ken Yan Ching; Hon, Chung Chau; Hui, Raymond Kin Hi; Wong, Raymond Tsz Yeung; Yip, Chi Wai; Zeng, Fanya; Leung, Frederick Chi Ching
Title: Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
  • Document date: 2016_11_28
    • ID: xuj4yymz_40
    Snippet: Work on developing a laboratory diagnosis of the SARS-CoV began immediately after the SARS outbreak, although an ideal diagnostic system is still being sought. Numerous protocols have been developed for the diagnosis of infectious viral diseases. Most of these protocols are PCR-based, and the remainder depends on measurable immune response. Several factors affect the choice of proper diagnosis techniques, including time, the availability of equip.....
    Document: Work on developing a laboratory diagnosis of the SARS-CoV began immediately after the SARS outbreak, although an ideal diagnostic system is still being sought. Numerous protocols have been developed for the diagnosis of infectious viral diseases. Most of these protocols are PCR-based, and the remainder depends on measurable immune response. Several factors affect the choice of proper diagnosis techniques, including time, the availability of equipment and expertise, the biological nature of the available samples, and the requirement of data output format (Table 2; ref. 10 ). The presence of the virus can be detected by molecular testing such as PCR and virus isolation. Measurable immune responses basically rely on SARS-CoV specific antibodies by enzyme-linked immunosorbent assay (ELISA).

    Search related documents:
    Co phrase search for related documents
    • available sample and ELISA immunosorbent assay: 1
    • available sample and immune response: 1, 2
    • available sample and immunosorbent assay: 1, 2
    • available sample and laboratory diagnosis: 1
    • available sample and molecular testing: 1
    • available sample and specific antibody: 1
    • available sample and viral disease: 1, 2
    • available sample and virus presence: 1, 2
    • biological nature and immune response: 1, 2, 3, 4
    • biological nature and SARS outbreak: 1, 2
    • diagnosis technique and ELISA immunosorbent assay: 1, 2
    • diagnosis technique and immunosorbent assay: 1, 2, 3
    • diagnosis technique and laboratory diagnosis: 1, 2, 3, 4, 5, 6, 7
    • diagnosis technique and molecular testing: 1